Nausea; High blood pressure; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea) and HYPERTENSION (High blood pressure) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), DOCOSAHEXAENOIC ACID (OMEGA 3 DHA [DOCOSAHEXAENOIC ACID]), DENOSUMAB (PROLIA), DEXTROMETHORPHAN HYDROBROMIDE (DELSYM), DILTIAZEM, LEVOTHYROXINE, LISINOPRIL, TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) and ASCORBIC ACID, RETINOL, TOCOPHEROL (OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced NAUSEA (Nausea) and HYPERTENSION (High blood pressure). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NAUSEA (Nausea) and HYPERTENSION (High blood pressure) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Blood pressure measurement: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was taken to the ER (emergency Room) for the reported events.   Most recent FOLLOW-UP information incorporated above includes: On 11-Feb-2021: No specific follow-up information recorded. This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jan-2021. The most recent information was received on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea) and HYPERTENSION (High blood pressure) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), DOCOSAHEXAENOIC ACID (OMEGA 3 DHA [DOCOSAHEXAENOIC ACID]), DENOSUMAB (PROLIA), DEXTROMETHORPHAN HYDROBROMIDE (DELSYM), DILTIAZEM, LEVOTHYROXINE, LISINOPRIL, TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) and ASCORBIC ACID, RETINOL, TOCOPHEROL (OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced NAUSEA (Nausea) and HYPERTENSION (High blood pressure). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NAUSEA (Nausea) and HYPERTENSION (High blood pressure) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Blood pressure measurement: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was taken to the ER (emergency Room) for the reported events.   Most recent FOLLOW-UP information incorporated above includes: On 11-Feb-2021: No specific follow-up information recorded.